Matches in Wikidata for { <http://www.wikidata.org/entity/Q81087251> ?p ?o ?g. }
Showing items 1 to 47 of
47
with 100 items per page.
- Q81087251 description "artículu científicu espublizáu n'abril de 2008" @default.
- Q81087251 description "scientific article published on 15 April 2008" @default.
- Q81087251 description "wetenschappelijk artikel" @default.
- Q81087251 description "наукова стаття, опублікована у квітні 2008" @default.
- Q81087251 name "Myeloablative 131I-tositumomab radioimmunotherapy in treating non-Hodgkin's lymphoma: comparison of dosimetry based on whole-body retention and dose to critical organ receiving the highest dose" @default.
- Q81087251 name "Myeloablative 131I-tositumomab radioimmunotherapy in treating non-Hodgkin's lymphoma: comparison of dosimetry based on whole-body retention and dose to critical organ receiving the highest dose" @default.
- Q81087251 type Item @default.
- Q81087251 label "Myeloablative 131I-tositumomab radioimmunotherapy in treating non-Hodgkin's lymphoma: comparison of dosimetry based on whole-body retention and dose to critical organ receiving the highest dose" @default.
- Q81087251 label "Myeloablative 131I-tositumomab radioimmunotherapy in treating non-Hodgkin's lymphoma: comparison of dosimetry based on whole-body retention and dose to critical organ receiving the highest dose" @default.
- Q81087251 prefLabel "Myeloablative 131I-tositumomab radioimmunotherapy in treating non-Hodgkin's lymphoma: comparison of dosimetry based on whole-body retention and dose to critical organ receiving the highest dose" @default.
- Q81087251 prefLabel "Myeloablative 131I-tositumomab radioimmunotherapy in treating non-Hodgkin's lymphoma: comparison of dosimetry based on whole-body retention and dose to critical organ receiving the highest dose" @default.
- Q81087251 P1433 Q81087251-371AD043-B4BD-415F-B330-3D4CAACABBB7 @default.
- Q81087251 P1476 Q81087251-C31AA5A6-D3C5-47BF-9E4D-F247545FE29C @default.
- Q81087251 P2093 Q81087251-26815AC0-7405-4A00-A707-6A994E0CE3C4 @default.
- Q81087251 P2093 Q81087251-C3293043-4373-4D89-B38D-9B85443353FC @default.
- Q81087251 P2093 Q81087251-E4C88D7D-4E48-4C34-ADDF-625D7225FF83 @default.
- Q81087251 P2093 Q81087251-FA086D5D-E075-493E-A3DA-E1D8CC1C8A1A @default.
- Q81087251 P2860 Q81087251-9DFF6D81-089F-4945-BD7F-68EF34A0672C @default.
- Q81087251 P304 Q81087251-209C5A61-7564-4872-8CC9-FECA53B2CBF4 @default.
- Q81087251 P31 Q81087251-AB6A83CE-485D-48BB-8F2F-908EAC50810A @default.
- Q81087251 P356 Q81087251-8910FEDC-A0AB-4A12-83D4-8366F004397D @default.
- Q81087251 P407 Q81087251-23ED841C-E11F-45AA-A483-D88A2DA55859 @default.
- Q81087251 P433 Q81087251-3732CF76-B957-440E-8DD4-410D4CF95DAC @default.
- Q81087251 P478 Q81087251-51B05C35-6B53-495E-AB8F-3A85304096E1 @default.
- Q81087251 P50 Q81087251-1B89E0AD-6729-4711-A879-A3143C49E68F @default.
- Q81087251 P50 Q81087251-B2879601-844D-4CB0-A436-54393E73D597 @default.
- Q81087251 P577 Q81087251-DA904740-3E9F-42D4-930C-18B533A9D19F @default.
- Q81087251 P698 Q81087251-CEA021DC-3FB1-4011-B693-06B39CDF8F03 @default.
- Q81087251 P356 JNUMED.107.043190 @default.
- Q81087251 P698 18413376 @default.
- Q81087251 P1433 Q7743608 @default.
- Q81087251 P1476 "Myeloablative 131I-tositumomab radioimmunotherapy in treating non-Hodgkin's lymphoma: comparison of dosimetry based on whole-body retention and dose to critical organ receiving the highest dose" @default.
- Q81087251 P2093 "Darrel R Fisher" @default.
- Q81087251 P2093 "Joseph G Rajendran" @default.
- Q81087251 P2093 "Larry D Durack" @default.
- Q81087251 P2093 "Ted A Gooley" @default.
- Q81087251 P2860 Q40587278 @default.
- Q81087251 P304 "837-844" @default.
- Q81087251 P31 Q13442814 @default.
- Q81087251 P356 "10.2967/JNUMED.107.043190" @default.
- Q81087251 P407 Q1860 @default.
- Q81087251 P433 "5" @default.
- Q81087251 P478 "49" @default.
- Q81087251 P50 Q50211582 @default.
- Q81087251 P50 Q50211588 @default.
- Q81087251 P577 "2008-04-15T00:00:00Z" @default.
- Q81087251 P698 "18413376" @default.